Sign inGet started

Parks Diane L.

Insider CIK 1781026 · KURA Director · CELU Director · SNGX Director · CTIC Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
SNGX SOLIGENIX, INC. D To issuer deriv2026-10-122026-10-13192— $00SEC↗
SNGX SOLIGENIX, INC. D To issuer deriv2026-10-122026-10-13121— $00SEC↗
SNGX SOLIGENIX, INC. D To issuer deriv2026-10-122026-10-1363— $00SEC↗
SNGX SOLIGENIX, INC. D To issuer deriv2026-10-122026-10-1356— $00SEC↗
SNGX SOLIGENIX, INC. D To issuer deriv2026-10-122026-10-13128— $00SEC↗
SNGX SOLIGENIX, INC. D To issuer deriv2026-10-122026-10-136— $00SEC↗
SNGX SOLIGENIX, INC. A Award deriv2026-09-172026-09-1878,947— $078,947SEC↗
SNGX SOLIGENIX, INC. A Award deriv2026-09-172026-09-1878,947— $078,947SEC↗
KURA Kura Oncology, Inc. A Award deriv2026-06-042026-06-0435,000— $035,000SEC↗
CELU Celularity Inc A Award2026-01-122026-01-1430,000— $0520,021SEC↗
CELU Celularity Inc A Award2026-01-122026-01-1530,000— $0520,021SEC↗
CELU Celularity Inc A Award deriv2025-12-292025-12-30156,250— $0518,774SEC↗
CELU Celularity Inc A Award2025-12-292025-12-30125,000— $0490,021SEC↗
CELU Celularity Inc A Award2025-12-192025-12-2267,416— $0365,021SEC↗
CELU Celularity Inc A Award2025-11-192025-11-2161,539— $0365,021SEC↗
SNGX SOLIGENIX, INC. A Award deriv2025-06-202025-06-2017,647— $017,647SEC↗
KURA Kura Oncology, Inc. A Award deriv2025-06-052025-06-0628,500— $028,500SEC↗
CELU Celularity Inc A Award deriv2024-12-192025-01-0784,746— $0362,524SEC↗
CELU Celularity Inc A Award2024-12-192025-01-0767,416— $0303,482SEC↗
SNGX SOLIGENIX, INC. A Award deriv2024-12-122024-12-138,646— $08,646SEC↗
KURA Kura Oncology, Inc. A Award deriv2024-06-052024-06-0726,000— $026,000SEC↗
SNGX SOLIGENIX, INC. A Award deriv2023-12-152023-12-1538,136— $038,136SEC↗
CTIC CTI BIOPHARMA CORP D To issuer deriv2023-06-262023-06-2680,000— $00SEC↗
CTIC CTI BIOPHARMA CORP D To issuer deriv2023-06-262023-06-2680,000— $00SEC↗
CTIC CTI BIOPHARMA CORP D To issuer deriv2023-06-262023-06-26120,000— $00SEC↗
CELU Celularity Inc A Award deriv2023-06-142023-06-16277,778— $0277,778SEC↗
CELU Celularity Inc A Award2023-06-142023-06-16199,921— $0236,066SEC↗
KURA Kura Oncology, Inc. A Award deriv2023-05-312023-06-0226,000— $026,000SEC↗
CTIC CTI BIOPHARMA CORP A Award deriv2023-04-052023-04-0780,000— $080,000SEC↗
SNGX SOLIGENIX, INC. A Award deriv2022-11-172022-11-2146,154— $0112,504SEC↗
CELU Celularity Inc A Award deriv2022-07-132022-07-1554,152— $054,152SEC↗
CELU Celularity Inc A Award2022-07-132022-07-1536,145— $036,145SEC↗
KURA Kura Oncology, Inc. A Award deriv2022-06-212022-06-2323,000— $023,000SEC↗
CELU Celularity Inc A Award deriv2022-06-022022-06-0342,413— $042,413SEC↗
CTIC CTI BIOPHARMA CORP A Award deriv2022-03-092022-03-1180,000— $080,000SEC↗
SNGX SOLIGENIX, INC. A Award deriv2021-09-232021-09-2429,126— $029,126SEC↗
KURA Kura Oncology, Inc. A Award deriv2021-06-222021-06-2323,000— $023,000SEC↗
SNGX SOLIGENIX, INC. A Award deriv2020-09-162020-09-1815,228— $015,228SEC↗
KURA Kura Oncology, Inc. A Award deriv2020-06-242020-06-2623,000— $023,000SEC↗
SNGX SOLIGENIX, INC. A Award deriv2020-06-182020-06-1913,500— $013,500SEC↗
KURA Kura Oncology, Inc. A Award deriv2019-10-142019-10-1630,000— $030,000SEC↗
KURA Kura Oncology, Inc. A Award deriv2019-10-142019-10-168,666— $08,666SEC↗
SNGX SOLIGENIX, INC. P Buy2019-09-232019-09-2314,940$0.93 $13.9K14,940SEC↗
SNGX SOLIGENIX, INC. A Award deriv2019-09-062019-09-1030,928— $030,928SEC↗
SNGX SOLIGENIX, INC. A Award deriv2019-07-082019-07-081,500— $01,500SEC↗